Type 2 cannabinoid receptor (CB2R)
Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity
15
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis
11
Original Article CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion
13
Jacob, Wolfgang (2007): Role of the Cannabinoid Receptor Type 1 (CB1) in Synaptic Plasticity, Memory and Emotionality. Dissertation, LMU München: Fakultät für Biologie
156
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
10
Original Article Activation of cannabinoid receptor type 2 reduces lung ischemia reperfusion injury through PI3K/Akt pathway
10
Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats
7
Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury
10
In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study
9
Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study
10
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health
9
Regulation of Adipose Tissue Metabolism by the Endocannabinoid System
13
MicroRNA-139 modulates Alzheimer's-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2.
12
Lower circulating endocannabinoid levels in children with autism spectrum disorder
11
Interaction Between L-Type Calcium Channels and Antagonist of Cannabinoid System on Anxiety in Male Rat
7
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
13
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
10
Identification of a bone morphogenetic protein type 2 receptor neutralizing antibody
6
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
8
Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity
36